THIRD HARMONIC BIO INC's ticker is and the CUSIP is 88427A107. A total of 50 filers reported holding THIRD HARMONIC BIO INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 10,907,859 | $44,940,379 | 6.08% |
| Stonepine Capital Management, LLC | 3,131,995 | $12,903,819 | 4.33% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $7,416,000 | 1.10% |
| BVF INC/IL | 4,365,933 | $17,987,644 | 0.66% |
| COMMODORE CAPITAL LP | 993,294 | $4,092,371 | 0.62% |
| Orbimed Advisors | 5,779,071 | $23,809,773 | 0.47% |
| Bain Capital Life Sciences Investors, LLC | 640,631 | $2,639 | 0.33% |
| EcoR1 Capital, LLC | 1,802,122 | $7,424,743 | 0.24% |
| GENERAL ATLANTIC, L.P. | 2,958,762 | $12,190,099 | 0.14% |
| Boxer Capital, LLC | 570,417 | $2,350 | 0.12% |
| RTW INVESTMENTS, LP | 534,687 | $2,202,910 | 0.05% |
| XTX Topco Ltd | 16,116 | $66,398 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 59,100 | $243,492 | 0.01% |
| Walleye Capital LLC | 50,000 | $206,000 | 0.00% |
| BAILARD, INC. | 10,400 | $42,848 | 0.00% |
| Leucadia National | 21,985 | $90,578 | 0.00% |
| BlackRock Inc. | 725,725 | $2,989,987 | 0.00% |
| Bank of New York Mellon Corp | 36,437 | $150,121 | 0.00% |
| LPL Financial LLC | 10,000 | $41,200 | 0.00% |
| Citadel Advisors | 10,724 | $44,183 | 0.00% |
This page lists THIRD HARMONIC BIO INC's shareholders in Q1 2023. To view THIRD HARMONIC BIO INC's shareholder history, click here.